by Clinical Neuropsychologist Online | Wednesday, February 26, 2025 | Dementia
Abstract INTRODUCTION The Clinical Dementia Rating (CDR) Scale is a gold standard for staging impairment in Alzheimer’s disease and other dementias (ADRD). The Quick Dementia Rating System (QDRS) offers similar results in 3 to 5 minutes without a trained...
by Clinical Neuropsychologist Online | Monday, February 24, 2025 | Dementia
Abstract INTRODUCTION Limited data exist on the utility of plasma biomarkers to predict incident abnormal amyloid positron emission tomography (PET). In this study we evaluate the association of plasma Alzheimer’s disease (AD) biomarkers with amyloid PET...
by Clinical Neuropsychologist Online | Monday, February 24, 2025 | Dementia
Abstract INTRODUCTION Physical activity is associated with greater myelin content in older individuals with cerebral small vessel disease (CSVD), a condition marked by demyelination. However, potential mechanisms underlying this relationship remain understudied....
by Clinical Neuropsychologist Online | Monday, February 24, 2025 | Dementia
Abstract INTRODUCTION Positron emission tomography (PET) imaging studies have shown that amyloid beta (Aβ) is significantly correlated with glucose metabolism in mild cognitive impairment independently of the apolipoprotein E (APOE) ε4 genotype. METHODS We used a...
by Clinical Neuropsychologist Online | Monday, February 24, 2025 | Dementia
Abstract INTRODUCTION Few studies have characterized the association of olfaction with dementia in detail across diverse sociodemographic subgroups. METHODS We examined the association of one-time-point olfactory status with incident dementia overall and by age, race,...
